ViaCyte, Inc. 's Role as a Leading Cell Therapy Company Bolstered With the Issuance of 20 Patents in 2012 /PRNewswire/ -- ViaCyte, Inc., a leading regenerative medicine company focused on developing new approaches to treat major diseases through the application of a stem cell-derived cell therapy, announced today that the Company was granted 20 ... (more)
http://www.biospace.com/news_story.aspx?StoryID=286285&full=1
http://www.biospace.com/news_story.aspx?StoryID=286285&full=1
No comments:
Post a Comment